# Comparison of Treximet & Imitrex as They Affect the Levels of Inflammatory Markers When the Patient is Actively Having a Migraine Headache

> **NCT01916395** · — · COMPLETED · sponsor: **Gary E. Ruoff, M.D.** · enrollment: 30 (actual)

## Conditions studied

- Migraine

## Interventions

- **DRUG:** sumatriptan and Treximet

## Key facts

- **NCT ID:** NCT01916395
- **Lead sponsor:** Gary E. Ruoff, M.D.
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2010-12
- **Final completion:** 2011-07
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2013-08-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01916395

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01916395, "Comparison of Treximet & Imitrex as They Affect the Levels of Inflammatory Markers When the Patient is Actively Having a Migraine Headache". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01916395. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*